TriMas Co. (NASDAQ:TRS) Director Shawn Sedaghat Purchases 554,149 Shares

TriMas Co. (NASDAQ:TRS) Director Shawn Sedaghat purchased 554,149 shares of TriMas stock in a transaction dated Monday, March 10th. The stock was bought at an average cost of $24.07 per share, with a total value of $13,338,366.43. Following the completion of the transaction, the director now owns 900,974 shares in the company, valued at approximately $21,686,444.18. This represents a 159.78 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.

Shawn Sedaghat also recently made the following trade(s):

• On Friday, March 7th, Shawn Sedaghat bought 249,597 shares of TriMas stock. The stock was bought at an average price of $23.83 per share, for a total transaction of $5,947,896.51.

TriMas Price Performance

Shares of TRS opened at $23.99 on Friday. The company has a 50 day moving average of $23.56 and a two-hundred day moving average of $25.05. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60. TriMas Co. has a twelve month low of $19.33 and a twelve month high of $28.51. The company has a market cap of $973.59 million, a price-to-earnings ratio of 37.48 and a beta of 0.65.

TriMas Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 28th were given a $0.04 dividend. The ex-dividend date was Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.67%. TriMas’s payout ratio is 27.12%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE increased its stake in TriMas by 127.3% during the 4th quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company’s stock valued at $86,400,000 after purchasing an additional 1,967,738 shares in the last quarter. Bellecapital International Ltd. purchased a new stake in shares of TriMas during the fourth quarter valued at $29,160,000. Impax Asset Management Group plc increased its position in shares of TriMas by 216.4% in the 3rd quarter. Impax Asset Management Group plc now owns 410,000 shares of the industrial products company’s stock valued at $10,467,000 after acquiring an additional 280,431 shares during the period. Raymond James Financial Inc. purchased a new position in TriMas in the 4th quarter worth $6,698,000. Finally, Wellington Management Group LLP lifted its position in TriMas by 10.7% during the 3rd quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company’s stock worth $66,872,000 after acquiring an additional 252,537 shares during the period. 99.42% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, BWS Financial reissued a “buy” rating and set a $40.00 price target on shares of TriMas in a research report on Friday, February 28th.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.